DD103559A5 - - Google Patents

Info

Publication number
DD103559A5
DD103559A5 DD169223A DD16922373A DD103559A5 DD 103559 A5 DD103559 A5 DD 103559A5 DD 169223 A DD169223 A DD 169223A DD 16922373 A DD16922373 A DD 16922373A DD 103559 A5 DD103559 A5 DD 103559A5
Authority
DD
German Democratic Republic
Application number
DD169223A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD103559A5 publication Critical patent/DD103559A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/101,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD169223A 1972-03-06 1973-03-05 DD103559A5 (US06590051-20030708-C00023.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00232294A US3833727A (en) 1972-03-06 1972-03-06 Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension

Publications (1)

Publication Number Publication Date
DD103559A5 true DD103559A5 (US06590051-20030708-C00023.png) 1974-02-05

Family

ID=22872572

Family Applications (1)

Application Number Title Priority Date Filing Date
DD169223A DD103559A5 (US06590051-20030708-C00023.png) 1972-03-06 1973-03-05

Country Status (19)

Country Link
US (1) US3833727A (US06590051-20030708-C00023.png)
AT (1) AT331966B (US06590051-20030708-C00023.png)
BE (1) BE796288A (US06590051-20030708-C00023.png)
CA (1) CA1015662A (US06590051-20030708-C00023.png)
CY (1) CY951A (US06590051-20030708-C00023.png)
DD (1) DD103559A5 (US06590051-20030708-C00023.png)
FR (1) FR2181786B1 (US06590051-20030708-C00023.png)
GB (1) GB1385648A (US06590051-20030708-C00023.png)
HK (1) HK23378A (US06590051-20030708-C00023.png)
HU (1) HU165714B (US06590051-20030708-C00023.png)
IE (1) IE37326B1 (US06590051-20030708-C00023.png)
IL (1) IL41610A (US06590051-20030708-C00023.png)
KE (1) KE2839A (US06590051-20030708-C00023.png)
LU (1) LU67144A1 (US06590051-20030708-C00023.png)
MY (1) MY7800295A (US06590051-20030708-C00023.png)
NL (1) NL176746C (US06590051-20030708-C00023.png)
PH (1) PH18901A (US06590051-20030708-C00023.png)
SE (1) SE400472B (US06590051-20030708-C00023.png)
ZA (1) ZA731505B (US06590051-20030708-C00023.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001421A (en) * 1971-10-27 1977-01-04 Syntex (U.S.A.) Inc. Thiazole cardiovascular agents
NZ196227A (en) * 1980-02-19 1984-09-28 Merck & Co Inc 1,2,5-thiadiazole derivative and ophthalmic compositions
US4521414A (en) * 1981-06-18 1985-06-04 The Texas A&M University System Ophthalmic compositions and their use for treating elevated intraocular pressure and glaucoma
US20110092507A1 (en) * 2009-10-20 2011-04-21 Chin-Tsai Fan Process for preparing R-(+)-3-morpholino-4-(3- tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole

Also Published As

Publication number Publication date
CY951A (en) 1978-12-22
AU5266273A (en) 1974-08-29
NL176746B (nl) 1985-01-02
ZA731505B (en) 1974-10-30
GB1385648A (en) 1975-02-26
IE37326B1 (en) 1977-06-22
KE2839A (en) 1978-05-26
MY7800295A (en) 1978-12-31
ATA195873A (de) 1975-12-15
HK23378A (en) 1978-05-12
FR2181786B1 (US06590051-20030708-C00023.png) 1976-05-14
CA1015662A (en) 1977-08-16
BE796288A (fr) 1973-09-05
NL176746C (nl) 1985-06-03
DE2310836A1 (de) 1973-09-20
LU67144A1 (US06590051-20030708-C00023.png) 1973-09-06
PH18901A (en) 1985-10-30
HU165714B (US06590051-20030708-C00023.png) 1974-10-28
AT331966B (de) 1976-09-10
DE2310836B2 (de) 1976-11-04
IE37326L (en) 1973-09-06
FR2181786A1 (US06590051-20030708-C00023.png) 1973-12-07
US3833727A (en) 1974-09-03
NL7302728A (US06590051-20030708-C00023.png) 1973-09-10
IL41610A (en) 1975-08-31
IL41610A0 (en) 1973-04-30
SE400472B (sv) 1978-04-03

Similar Documents

Publication Publication Date Title
AU465394B2 (US06590051-20030708-C00023.png)
JPS4990599A (US06590051-20030708-C00023.png)
FR2180725B1 (US06590051-20030708-C00023.png)
FR2209530A1 (US06590051-20030708-C00023.png)
FR2181786B1 (US06590051-20030708-C00023.png)
FR2207518A5 (US06590051-20030708-C00023.png)
JPS4948960A (US06590051-20030708-C00023.png)
JPS5128391Y2 (US06590051-20030708-C00023.png)
FR2181820B1 (US06590051-20030708-C00023.png)
JPS526544B2 (US06590051-20030708-C00023.png)
JPS498391U (US06590051-20030708-C00023.png)
JPS49103073U (US06590051-20030708-C00023.png)
JPS4936251Y1 (US06590051-20030708-C00023.png)
JPS4975221U (US06590051-20030708-C00023.png)
JPS4968631U (US06590051-20030708-C00023.png)
JPS494248U (US06590051-20030708-C00023.png)
JPS4991699U (US06590051-20030708-C00023.png)
JPS4993587U (US06590051-20030708-C00023.png)
CH578748A5 (US06590051-20030708-C00023.png)
CH576317A5 (US06590051-20030708-C00023.png)
CH574728A5 (US06590051-20030708-C00023.png)
CH578671A5 (US06590051-20030708-C00023.png)
CH578631A5 (US06590051-20030708-C00023.png)
CH578563A5 (US06590051-20030708-C00023.png)
CH576937A5 (US06590051-20030708-C00023.png)